A detailed history of Private Capital Management, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Private Capital Management, LLC holds 133,880 shares of LGND stock, worth $15.2 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
133,880
Previous 134,505 0.46%
Holding current value
$15.2 Million
Previous $11.3 Million 18.33%
% of portfolio
1.57%
Previous 1.42%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$82.7 - $110.11 $51,687 - $68,818
-625 Reduced 0.46%
133,880 $13.4 Million
Q2 2024

Aug 14, 2024

BUY
$68.53 - $87.91 $9.22 Million - $11.8 Million
134,505 New
134,505 $11.3 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Private Capital Management, LLC Portfolio

Follow Private Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Management, LLC with notifications on news.